Literature DB >> 18391721

Analysis of interleukin-8, interleukin-10, and tumor necrosis factor-alpha in the cerebrospinal fluid of patients with cervical spondylotic myelopathy.

Keigo Ito1, Yukihiro Matsuyama, Yasutsugu Yukawa, Fumihiko Kato, Naoki Ishiguro.   

Abstract

STUDY
DESIGN: Retrospective cohort study.
OBJECTIVE: The expression of interleukin-8 (IL-8), IL-10, and tumor necrosis factor-alpha (TNF-alpha) were measured in the cerebrospinal fluid (CSF) of patients with cervical myelopathy. The purpose of this study was to examine whether the CSF levels of those 3 cytokines differ significantly among 3 groups of patients with different diseases.
METHODS: IL-8, IL-10, and TNF-alpha levels were analyzed using enzyme-linked immune assay. CSF samples were collected from 3 groups of patients. The cervical spondylotic myelopathy (CSM) group consisted of 35 patients. The ossification of the posterior longitudinal ligament group [(OPLL) group] consisted of 7 patients, and the control group consisted of 12 patients. The concentration of IL-8 was 69.0+/-35.2 pg/mL in the CSM group, 82.1+/-46.7 pg/mL in the OPLL group, and 43.5+/-20.9 pg/mL in the control group. The concentration of IL-8 was significantly higher in the CSM and OPLL groups than in the control group (P<0.05). There was no significant difference between the CSM group and OPLL group. The concentration of IL-10 and TNF-alpha in all groups was below the sensitivity of the measurements.
CONCLUSIONS: In this study, the concentration of IL-8 was high in CSM and OPLL patients. However, the concentration of IL-10 and TNF-alpha was below the sensitivity of the measurements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391721     DOI: 10.1097/BSD.0b013e31806458b3

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  5 in total

1.  High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Shunsuke Meshitsuka; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2010-05-20       Impact factor: 3.134

2.  Tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2009-06-19       Impact factor: 3.134

3.  Interleukin-6 Serum Levels Are Elevated in Individuals with Degenerative Cervical Myelopathy and Are Correlated with Symptom Severity.

Authors:  Shengchao Du; Yuan Sun; Bizeng Zhao
Journal:  Med Sci Monit       Date:  2018-10-17

4.  A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and Time.

Authors:  Benjamin M Davies; Oliver Mowforth; Aref-Ali Gharooni; Lindsay Tetreault; Aria Nouri; Rana S Dhillon; Josef Bednarik; Allan R Martin; Adam Young; Hitoshi Takahashi; Timothy F Boerger; Virginia Fj Newcombe; Carl Moritz Zipser; Patrick Freund; Paul Aarne Koljonen; Ricardo Rodrigues-Pinto; Vafa Rahimi-Movaghar; Jefferson R Wilson; Shekar N Kurpad; Michael G Fehlings; Brian K Kwon; James S Harrop; James D Guest; Armin Curt; Mark R N Kotter
Journal:  Global Spine J       Date:  2022-02

5.  Cytokine concentrations in the cerebrospinal fluid of great danes with cervical spondylomyelopathy.

Authors:  P Martin-Vaquero; R C da Costa; S A Moore; A C Gross; T D Eubank
Journal:  J Vet Intern Med       Date:  2014-06-25       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.